While these liver-specific ABHD5-deficient mice similarly developed hepatic steatosis associated with decreased hepatic TAG hydrolase activity and reduced FA oxidation rates, they exhibited plasma TAG concentrations and VLDL production rates comparable to their wild-type littermates. This evidence concerns the gene ABHD5 and fatty liver disease.